Skip to main content
All lobbying filings

CROSSROADS STRATEGIES, LLC

CROSSROADS STRATEGIES, LLC filed a Q2 report for ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) on July 20, 2026, reporting $50,000 in lobbying income.

Lobbying for ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · medical technology association

All filings by CROSSROADS STRATEGIES, LLC · Everything ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 2
  • JACKSON KENDRIC STUTEVILLE New on this filing
    Previously held: Legislative Intern, Rep. Kendra Horn
  • MARC NUMEDAHL New on this filing
    Previously held: Legislative Director, Rep. Dave Loebsack; Military Legislative Assistant, Rep. Rick Larsen

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 5

General education to advance policies that support innovation in the medical device industry. Issues related to coverage and reimbursement of diagnostic tests, including issues related to FDA regulation of medical devices. Issues related to medical device sterilization. Policy issues related to the regulation of artificial intelligence for medical technology. Issues related to cybersecurity of medical devices manufactured in China. Policies that could impact supply chain for medical technology. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.

General education to advance policies that support innovation in the medical device industry. Issues related to the coverage and reimbursement of medical devices and technology, including AI. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.

Policies impacting the supply chain and manufacturing of medical devices and technology including tariffs.

Discussions regarding implementation of medtech related provisions; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260).

Policies impacting third party repair of medtech. Issues related to competitive bidding in the FY2027 National Defense Authorization Act (H.R.8800/S.4784).

 Bills named in this filing 4
  • H.R. 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • H.R. 9260
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
  • H.R. 8800
    National Defense Authorization Act for Fiscal Year 2027
  • S. 4784
    National Defense Authorization Act for Fiscal Year 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem